| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts presented at the American Society of Clinical Oncology conference: how completely are trials reported?
|
Hopewell, Sally
|
|
2005
|
2 |
3 |
p. 265-268
|
artikel
|
| 2 |
A critical history of individual and collective ethics in the lineage of Lellouch and Schwartz
|
Heilig, Charles M
|
|
2005
|
2 |
3 |
p. 244-253
|
artikel
|
| 3 |
Book Review: Sample size calculations in clinical research
|
Rochon, James
|
|
2005
|
2 |
3 |
p. 269-270
|
artikel
|
| 4 |
Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): a critical appraisal
|
Mann, Howard
|
|
2005
|
2 |
3 |
p. 233-243
|
artikel
|
| 5 |
Ethics and evidence in clinical trials
|
Goodman, Steven N
|
|
2005
|
2 |
3 |
p. 195-196
|
artikel
|
| 6 |
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice
|
Simmonds, Mark C
|
|
2005
|
2 |
3 |
p. 209-217
|
artikel
|
| 7 |
Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?
|
Fergusson, Dean
|
|
2005
|
2 |
3 |
p. 218-232
|
artikel
|
| 8 |
The use of systematic reviews when designing studies
|
Cooper, Nicola J
|
|
2005
|
2 |
3 |
p. 260-264
|
artikel
|
| 9 |
Unblinding of trial participants to their treatment allocation: lessons from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
|
Dinnett, Eleanor M
|
|
2005
|
2 |
3 |
p. 254-259
|
artikel
|
| 10 |
Where's the utility in Bayesian data-monitoring of clinical trials?
|
Ashby, Deborah
|
|
2005
|
2 |
3 |
p. 197-208
|
artikel
|
Tijdschrift beschrijving